采用以顺铂为主的联合化疗加放疗对１２１例晚期宫颈癌进行综合治疗与单纯放疗对照，作前瞻性近期疗效比较。结果提示，前者ＣＲ８６．４％，ＰＲ４．５％；后者ＣＲ４３．６％，ＰＲ２３．６％，两者差异显著（Ｐ＜０．０１）．作者认为：首先以低剂量顺铂联合化疗，继以全量放疗的综合治疗方案，特别适用于晚期宫颈癌伴有合并症或放疗、手术受限的特殊类型（简称高危型）病人，有可能提高其生存率。 Using cisplatin-based combination chemotherapy plus radiotherapy on 121 cases of advanced cervical cancer combined with radiotherapy control, for prospective short-term efficacy comparison. The results suggest that the former CR86.4%, PR4.5%; the latter CR43.6%, PR23.6%, the difference was significant (P <0.01). The authors believe that: first low-dose cisplatin combined with chemotherapy, followed by a full dose of radiotherapy comprehensive treatment program, especially for advanced cervical cancer with comorbidities or radiotherapy, surgery limited special type (referred to as high-risk type) patients may increase Its survival rate.